[Clinico-experimental basis for regional and systemic administration of thiopoietins in liver cirrhosis. Report I].

@article{Borisov2001ClinicoexperimentalBF,
  title={[Clinico-experimental basis for regional and systemic administration of thiopoietins in liver cirrhosis. Report I].},
  author={Andrey Borisov and L A Kozhemiakin and A. E. Antushevich and O S Ketlinskaia and V A Kashenko and S. V. Chepur and V V Katsalukha and E L Vasiukova and A O Novichenkov and I E Motushchuk},
  journal={Vestnik khirurgii imeni I. I. Grekova},
  year={2001},
  volume={160 4},
  pages={32-8}
}
The authors present results of studying the effectiveness of a new class of medicines--preparations of the group "Glutoxim" (Molixan, Redoxell, Bikvolit, Liglutin) obtained on the model of experimental cirrhosis of the liver in 76 white rats caused by dimethylnitrosamin, and describe their first experience with using thiopoietins in 24 patients with cirrhosis of the liver in a surgical clinic. It was found that three weeks of treatment with Molixan and Bikvolit gave a significant… CONTINUE READING